An updated review of lipid‐modifying therapy-Reference-Cited by-同舟云学术

An updated review of lipid‐modifying therapy

Published:2019-04-21 Issue:2 Volume:211 Page:87-92
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Simons Leon A¹²

Affiliation:

1. UNSW Sydney Sydney NSW

2. St Vincent's Hospital Sydney NSW

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.50142

Reference70 articles.

1. Interpretation of the evidence for the efficacy and safety of statin therapy

2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

4. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

5. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta‐analysis of individual data from 27 randomised trials;Cholesterol Treatment Trialists’ Collaborators;Lancet,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. They’re sicker than we think: an exploratory study profiling the cardio-metabolic health in a sample of adults with pre-diabetes in Aotearoa New Zealand;Journal of Primary Health Care;2022-08-30

2. Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis;Frontiers in Molecular Biosciences;2022-05-25

3. Serum Metabolomics Reveals Underlying Mechanisms of Cholesterol‐Lowering Effects of Oat Consumption: A Randomized Controlled Trial in a Mildly Hypercholesterolemic Population;Molecular Nutrition & Food Research;2021-04-21

4. Ceramides and other sphingolipids as drivers of cardiovascular disease;Nature Reviews Cardiology;2021-03-26

5. Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis;Journal of Clinical Lipidology;2020-11